Bahrain has become the second nation in the world to approve the emergency use of the Pfizer-BioNTech coronavirus vaccine.
The state-run Bahrain News Agency made the announcement on Friday night, following .
"The approval of the Pfizer/BioNTech vaccine will add a further important layer to the kingdom's national COVID-19 response," said Mariam al-Jalahma, CEO of the National Health Regulatory Authority, according to a statement carried by BNA.
It did not specify when it would begin the rollout of the vaccine by US pharmaceuticals giant Pfizer and its German partner BioNTech.
Britain on Wednesday said it approved the COVID-19 vaccine for general use, with plans to start rolling it out next week.
In November, the small Gulf kingdom of Bahrain approved the use of China's Sinopharm vaccine on frontline healthcare workers.
Bahrain has so far recorded more than 87,000 COVID-19 cases, including 341 deaths.
"This authorisation is a goal we have been working toward since we first declared that science will win," said Lindsey Dietschi, Pfizer representative in the Gulf, according to BNA.
Britain, striving to tamp down any public unease after US and European officials queried the rapid process.
Companies have been racing to find a vaccine for the coronavirus, which has killed over 1.5 million people and infected more than 65 million since it emerged in China in December of last year.
People in Australia must stay at least 1.5 metres away from others. Check your jurisdiction's restrictions on gathering limits.
If you are experiencing cold or flu symptoms, stay home and arrange a test by calling your doctor or contact the Coronavirus Health Information Hotline on 1800 020 080.
Please check the relevant guidelines for your state or territory: , , , , , , ,
